Accès gratuit
Numéro
Med Sci (Paris)
Volume 21, Numéro 3, Mars 2005
Page(s) 284 - 289
Section M/S revues
DOI https://doi.org/10.1051/medsci/2005213284
Publié en ligne 15 mars 2005
  1. Wong CG, Gibson KM, Snead OC 3rd. From the street to the brain : neurobiology of the recreational drug gamma-hydroxybutyric acid. Trends Pharmacol Sci 2004; 25 : 29–34. [Google Scholar]
  2. Laborit H, Jouany JM, Gerard J, Fabiani F. Generalities concerning the experimental study and clinical use of gamma hydroxybutyrate of Na. Agressologie 1960; 1 : 397–406. [Google Scholar]
  3. Borgen LA, Cook HN, Hornfeldt CS, Fuller DE. Sodium oxybate (GHB) for treatment of cataplexy. Pharmacotherapy 2002; 22 : 798–9. [Google Scholar]
  4. Hedou G, Chasserot-Golaz S, Kemmel V, et al. Immunohistochemical studies of the localization of neurons containing the enzyme that synthesizes dopamine, GABA, or gamma-hydroxybutyrate in the rat substantia nigra and striatum. J Comp Neurol 2000; 426 : 549–60. [Google Scholar]
  5. Maitre M. The gamma-hydroxybutyrate signalling system in brain : organization and functional implications. Prog Neurobiol 1997; 51 : 337–61. [Google Scholar]
  6. Muller C, Viry S, Miehe M, et al. Evidence for a gamma-hydroxybutyrate (GHB) uptake by rat brain synaptic vesicles. J Neurochem 2002; 80 : 899–904. [Google Scholar]
  7. Vayer P, Maitre M. Regional differences in depolarization-induced release of gamma-hydroxybutyrate from rat brain slices. Neurosci Lett 1988; 87 : 99–103. [Google Scholar]
  8. Benavides J, Rumigny JF, Bourguignon JJ, et al. A high-affinity, Na+-dependent uptake system for gamma-hydroxybutyrate in membrane vesicles prepared from rat brain. J Neurochem 1982; 38 : 1570–5. [Google Scholar]
  9. McCormick SJ, Tunnicliff G. Inhibitors of synaptosomal gamma-hydroxybutyrate transport. Pharmacology 1998; 57 : 124–31. [Google Scholar]
  10. Benavides J, Rumigny JF, Bourguignon JJ, et al. High affinity binding sites for gamma-hydroxybutyric acid in rat brain. Life Sci 1982; 30 : 953–61. [Google Scholar]
  11. Hechler V, Gobaille S, Maitre M. Selective distribution pattern of gamma-hydroxybutyrate receptors in the rat forebrain and midbrain as revealed by quantitative autoradiography. Brain Res 1992; 572 : 345–8. [Google Scholar]
  12. Snead OC, 3rd. The ontogeny of 3Hgamma-hydroxybutyrate and 3HGABAB binding sites : relation to the development of experimental absence seizures. Brain Res 1994; 659 : 147–56. [Google Scholar]
  13. Ratomponirina C, Hode Y, Hechler V, Maitre M. Gamma-hydroxybutyrate receptor binding in rat brain is inhibited by guanyl nucleotides and pertussis toxin. Neurosci Lett 1995; 189 : 51–3. [Google Scholar]
  14. Andriamampandry C, Taleb O, Viry S, et al. Cloning and characterization of a rat brain receptor that binds the endogenous neuromodulator gamma-hydroxybutyrate (GHB). FASEB J 2003; 17 : 1691–3. [Google Scholar]
  15. Ratomponirina C, Gobaille S, Hode Y, et al. Sulpiride, but not haloperidol, upregulates gamma-hydroxybutyrate receptors in vivo and in cultured cells. Eur J Pharmacol 1998; 346 : 331–7. [Google Scholar]
  16. Kemmel V, Taleb O, Andriamampandry C, et al. Gamma-hydroxybutyrate receptor function determined by stimulation of rubidium and calcium movements from NCB-20 neurons. Neuroscience 2003; 116 : 1021–31. [Google Scholar]
  17. Snead OC 3rd. Evidence for a G protein-coupled gamma-hydroxybutyric acid receptor. J Neurochem 2000; 75 : 1986–96. [Google Scholar]
  18. Cash CD, Gobaille S, Kemmel V, et al. Gamma-hydroxybutyrate receptor function studied by the modulation of nitric oxide synthase activity in rat frontal cortex punches. Biochem Pharmacol 1999; 58 : 1815–9. [Google Scholar]
  19. Vayer P, Gobaille S, Mandel P, Maitre M. 3’-5’ cyclic-guanosine monophosphate increase in rat brain hippocampus after gamma-hydroxybutyrate administration. Prevention by valproate and naloxone. Life Sci 1987; 41 : 605–10. [Google Scholar]
  20. Kemmel V, Taleb O, Perard A, et al. Neurochemical and electrophysiological evidence for the existence of a functional gamma-hydroxybutyrate system in NCB- 20 neurons. Neuroscience 1998; 86 : 989–1000. [Google Scholar]
  21. Maitre M, Hechler V, Vayer P, et al. A specific gamma-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties. J Pharmacol Exp Ther 1990; 255 : 657–63. [Google Scholar]
  22. Howard SG, Feigenbaum JJ. Effect of gamma-hydroxybutyrate on central dopamine release in vivo. A microdialysis study in awake and anesthetized animals. Biochem Pharmacol 1997; 53 : 103–10. [Google Scholar]
  23. Brancucci A, Berretta N, Mercuri NB, Francesconi W. Gamma-hydroxybutyrate and ethanol depress spontaneous excitatory postsynaptic currents in dopaminergic neurons of the substantia nigra. Brain Res 2004; 997 : 62–6. [Google Scholar]
  24. Gobaille S, Hechler V, Andriamampandry C, et al. gamma-hydroxybutyrate modulates synthesis and extracellular concentration of gamma-aminobutyric acid in discrete rat brain regions in vivo. J Pharmacol Exp Ther 1999; 290 : 303–9. [Google Scholar]
  25. Hechler V, Gobaille S, Bourguignon JJ, Maitre M. Extracellular events induced by gamma-hydroxybutyrate in striatum : a microdialysis study. J Neurochem 1991; 56 : 938–44. [Google Scholar]
  26. Lingenhoehl K, Brom R, Heid J, et al. Gamma-hydroxybutyrate is a weak agonist at recombinant GABAB receptors. Neuropharmacology 1999; 38 : 1667–73. [Google Scholar]
  27. Kaupmann K, Cryan JF, Wellendorph P, et al. Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABAB(1)-deficient mice. Eur J Neurosci 2003; 18 : 2722–30. [Google Scholar]
  28. Berton F, Brancucci A, Beghe F, et al. Gamma-hydroxybutyrate inhibits excitatory postsynaptic potentials in rat hippocampal slices. Eur J Pharmacol 1999; 380 : 109–16. [Google Scholar]
  29. Godbout R, Jelenic P, Labrie C, et al. Effect of gamma-hydroxybutyrate and its antagonist NCS-382 on spontaneous cell firing in the prefrontal cortex of the rat. Brain Res 1995; 673 : 157–60. [Google Scholar]
  30. Vacher CM, Bettler B. GABAB receptors as potential therapeutic targets. Curr Drug Target CNS Neurol Disord 2003; 2 : 248–59. [Google Scholar]
  31. Vayer P, Mandel P, Maitre M. Conversion of gamma-hydroxybutyrate to gamma-aminobutyrate in vitro. J Neurochem 1985; 45 : 810–4. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.